WSJ:
The Securities and Exchange Commission is investigating trading of Schering-Plough Corp. shares ahead of the announcement of its merger with Merck & Co., people familiar with the matter said.
The investigation is focusing on whether people trading the pharmaceutical company’s stock in late February or early March were using inside information about the merger talks, which concluded in a deal announced Monday, March 9.
Ai note: SEC? SEC could not spot frauds with much more consequences. But nice try.What about looking on bank stocks? I think there could be much more inside information around during the last 18 months..
Sphere: Related Content
More on this topic
(What's this?)
Drug Companies: A Powerhouse of Profits
(Investment U, 5/8/09)
Guest post: Former Countrywide head Mozilo is charged by the SEC
(naked capitalism, 6/4/09)
Orko Silver Corp. Announces Intention to Terminate Securities and Exchange Commission Reporting O...
(Orko Silver Corp. Blogspot, 4/3/09)
Related posts:
Post a Comment